PROJECT TEAM
Louise Møller Jørgensen, MD, PhD
Consultant neurosurgeon, Associate Professor with function as innovation ambassador
Center for Rheumatology and Spine Diseases, Copenhagen University Hospital
THE NEED
Costly and invasive therapies like spinal fusion surgery, deep brain stimulation, or intensive rehabilitation are often performed on patients who may not benefit sufficiently, leading to unnecessary procedures, risks of complications, and prolonged suffering. There is currently no reliable screening tool to identify which patients will respond best to such therapies. Clinicians need a precise and non-invasive method to make evidence-based treatment decisions.
THE SOLUTION
Our patented fMRI-compatible electrical stimulator safely combines electrical stimulation with functional MRI to measure brain responses in real time. By creating a personalized electroceutical fMRI fingerprint, clinicians can predict the likely outcome of a given therapy before committing to treatment. This approach optimizes patient selection, reduces unnecessary surgeries, and allows for individualized adjustment of stimulation parameters in a single hospital visit.
fMRI Fingerpoint - Rigshospitalet
Call 1 - 2022
500.000 DKK
Clinical Area
Neurology
Technology
Digital health
PROJECT SUMMARY
This project uses patented fMRI tech combining electrical stimulation and imaging to create an “electroceutical fingerprint” that predicts treatment response, helping doctors identify patients most likely to benefit from costly therapies like surgery or neuromodulation.
CLINICAL IMPACT
The solution can reduce futile surgeries, minimize complications, and shorten treatment times. For patients, this means more effective therapy, fewer risks, and better outcomes. For healthcare systems, it translates into significant cost savings and more efficient use of clinical resources, particularly for high-cost therapies like neuromodulation and rehabilitation programs.